Tag: #cancertherapy

The expected CAGR of global urothelial carcinoma treatment market is tend to be around 20% in the mentioned forecast period. The market was valued at USD 0.81 billion in 2022, and it would grow upto USD 3.48 billion by 2030

The global non-small cell lung cancer diagnostics market is expected to reach USD 3,463.37 million by 2028 from USD 1,291.66 million in 2020, growing at a steady CAGR of 13.2% in the forecast period of 2021 to 2028.